|
WHSC1L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.25650000024369E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.158400E-04 |
| Normal-vs-Stage2 |
4.973800E-04 |
| Normal-vs-Stage3 |
2.69610000991349E-09 |
| Normal-vs-Stage4 |
1.75751000000002E-05 |
| Stage1-vs-Stage2 |
3.306800E-01 |
| Stage1-vs-Stage3 |
7.025800E-04 |
| Stage1-vs-Stage4 |
4.712400E-02 |
| Stage2-vs-Stage3 |
1.599040E-01 |
| Stage2-vs-Stage4 |
5.496400E-01 |
| Stage3-vs-Stage4 |
4.473600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.89089999996983E-07 |
| Normal-vs-AfricanAmerican |
6.816000E-04 |
| Normal-vs-Asian |
2.775800E-01 |
| Caucasian-vs-AfricanAmerican |
9.851000E-01 |
| Caucasian-vs-Asian |
4.947800E-01 |
| AfricanAmerican-vs-Asian |
5.582800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32809999997541E-07 |
| Normal-vs-Female |
1.404040E-04 |
| Male-vs-Female |
7.191800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.717800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.613420E-04 |
| Normal-vs-Age(61-80Yrs) |
1.71030001272499E-09 |
| Normal-vs-Age(81-100Yrs) |
1.992910E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.196400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.745630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.265160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.664100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.589900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.778000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.387600E-01 |
| Normal-vs-Grade 2 |
9.988400E-04 |
| Normal-vs-Grade 3 |
1.837300311891E-10 |
| Normal-vs-Grade 4 |
2.78409999998619E-06 |
| Grade 1-vs-Grade 2 |
1.177960E-02 |
| Grade 1-vs-Grade 3 |
1.70331999999052E-05 |
| Grade 1-vs-Grade 4 |
1.077100E-03 |
| Grade 2-vs-Grade 3 |
4.199700E-04 |
| Grade 2-vs-Grade 4 |
1.349580E-02 |
| Grade 3-vs-Grade 4 |
8.511800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.428400E-04 |
| Normal-vs-ccB subtype |
1.08160000000801E-06 |
| ccA subtype-vs-ccB subtype |
2.160400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.36899999961749E-07 |
| Normal-vs-N1 |
3.250000E-01 |
| N0-vs-N1 |
7.234000E-01 |
|
|
